3-[1-(3-氨基丙基)-1H-吲哚-3-基]-4-(1-甲基-1H-吲哚-3-基)-1H-吡咯-2,5-二酮单乙酸盐
中文名称 | 3-[1-(3-氨基丙基)-1H-吲哚-3-基]-4-(1-甲基-1H-吲哚-3-基)-1H-吡咯-2,5-二酮单乙酸盐 |
---|---|
中文同义词 | 3-[1-(3-氨基丙基)-1H-吲哚-3-基]-4-(1-甲基-1H-吲哚-3-基)-1H-吡咯-2,5-二酮单乙酸盐;BISINDOLYLMALEIMIDE VIII醋酸盐;化合物BISINDOLYLMALEIMIDE VIII ACETATE;RO 31-7549 ACETATE; BIS VIII ACETATE;3-(1-(3-氨基丙基)-1H-吲哚-3-基)-4-(1-甲基-1H-吲哚-3-基)-1H-吡咯-2,5-二酮 乙酸盐 |
英文名称 | Bisindolylmaleimide VIII acetate salt |
英文同义词 | BisindolylMaleiMide VIII . AcOH [Ro 31-7549];BISINDOLYLMALEIMIDE VIII ACETATE SALT;RO 31-7549 ACETATE;3-[1-(3-Aminopropyl)-1H-indol-3-yl]-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione monoacetate;Bis VIII acetate;1H-Pyrrole-2,5-dione, 3-[1-(3-aminopropyl)-1H-indol-3-yl]-4-(1-methyl-1H-indol-3-yl)-, acetate (1:1);protein,Bisindolylmaleimide VIII acetate,Ro 31-7549,Inhibitor,inhibit,Fas,Bis VIII,Apoptosis,autoimmune,Protein kinase C,diseases,kinase,cell-mediated,Bisindolylmaleimide VIII,PKC;3-(1-(3-Aminopropyl)-1H-indol-3-yl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione acetate |
CAS号 | 138516-31-1 |
分子式 | C24H22N4O2 |
分子量 | 398.464 |
EINECS号 | |
相关类别 | 对照品;inhibitor |
Mol文件 | 138516-31-1.mol |
结构式 | ![]() |
3-[1-(3-氨基丙基)-1H-吲哚-3-基]-4-(1-甲基-1H-吲哚-3-基)-1H-吡咯-2,5-二酮单乙酸盐 性质
储存条件 | -20°C |
---|---|
溶解度 | 溶于二甲基亚砜 |
形态 | 红色粉末。 |
颜色 | 棕至红棕色 |
Rat Brain PKC 158 nM (IC 50 ) |
PKC-α 53 nM (IC 50 ) |
PKC-βI 195 nM (IC 50 ) |
PKC-βII 163 nM (IC 50 ) |
PKC-γ 213 nM (IC 50 ) |
PKC-ε 175 nM (IC 50 ) |
Bisindolylmaleimide VIII acetate (Ro 31-7549 acetate; 5 μM; 8, 12 hours) dramatically increases TRA-8-induced cell death in time-dependent and TRA-8 dose-dependent manners.
Bisindolylmaleimide VIII acetate (5 μM; 6 hours) significantly decreases procaspase-8 at 4 h and completely disappeares at 6 h after the combined treatment with TRA-8.
Apoptosis Analysis
Cell Line: | 1321N1 cells |
Concentration: | 5 μM |
Incubation Time: | 8, 12 hours |
Result: | Dramatically increased TRA-8-induced cell death in time-dependent and TRA-8 dose-dependent manners. |
Western Blot Analysis
Cell Line: | 1321N1 cells |
Concentration: | 5 μM |
Incubation Time: | 6 hours |
Result: | Significantly decreased procaspase-8 at 4 h and completely disappeared at 6 h. |
Bisindolylmaleimide VIII acetate (Ro 31-7549 acetate; 100 μg; IP; every other day for three doses) results in nearly complete tumor regression combined toTRA-8. The treatment with Bisindolylmaleimide VIII acetate alone does not induce significant tumor regression.
Animal Model: |
6-8-week-old female NOD/SCID mice.
|
Dosage: | 100 μg |
Administration: | IP; every other day for three doses |
Result: | Resulted in nearly complete tumor regression combined toTRA-8. |
安全信息
海关编码 | 2925199590 |
---|